¹⁸F-FDG · Fluorodeoxyglucose
Glucose analog labeled with fluorine-18, taken up by cells with increased glucose metabolism. Reference PET tracer in oncology, cardiology and infectious diseases.
Glucose analog labeled with fluorine-18, taken up by cells with increased glucose metabolism. Reference PET tracer in oncology, cardiology and infectious diseases.
Peptide ligand targeting prostate-specific membrane antigen (PSMA). Reference for prostate cancer assessment (biochemical recurrence, high-risk staging).
Somatostatin analog binding with high affinity to SSTR2 receptor. Reference for imaging well-differentiated neuroendocrine tumors (NETs).
Tyrosine analog labeled with fluorine-18, taken up by the amino acid transport system (LAT). Reference for imaging primary brain tumors and recurrence/radionecrosis differential.
Choline analog labeled with fluorine-18, taken up by cells with increased phospholipid metabolism. Main indications: prostate cancer (recurrence) and parathyroid adenomas.
Fibroblast Activation Protein (FAP) inhibitor, expressed on activated fibroblasts of tumor stroma. Emerging pan-oncological tracer in clinical evaluation.
PSMA ligand labeled with fluorine-18 with very low urinary excretion (major advantage for pelvis). European reference for prostate cancer assessment.
PSMA ligand labeled with fluorine-18, first PSMA radiotracer approved by FDA. Assessment of metastatic or recurrent prostate cancer.
Dopamine precursor labeled with fluorine-18. Imaging of dopaminergic system (Parkinson), neuroendocrine tumors and gliomas.
Bone tracer by incorporation in hydroxyapatite. Detection of bone metastases and skeletal pathologies. Pre-FDG reference in osteology.
Tau protein (PHF) deposit tracer labeled with fluorine-18. Imaging of Alzheimer's disease and tauopathies. EMA approval 2024.
Family of 3 β-amyloid plaque tracers with fluorine-18 (Neuraceq, Vizamyl, Amyvid). Diagnostic imaging of Alzheimer's disease.
Somatostatin analog (DOTA-D-Phe¹-Tyr³-octreotide) with high affinity for SSTR2. Alternative to DOTATATE for NET imaging.
Essential amino acid labeled with carbon-11. Imaging of primary brain tumors and gliomas. Historical reference for amino acids in PET.
Choline labeled with carbon-11. Imaging of cells with high membrane metabolism. Hospital alternative to ¹⁸F-choline.
Ammonia labeled with nitrogen-13. PET myocardial perfusion imaging. Reference for absolute coronary blood flow quantification.
Water labeled with oxygen-15. Gold standard reference for absolute cerebral and myocardial blood flow quantification. Free diffusion.
Trastuzumab antibody (anti-HER2) labeled with zirconium-89. ImmunoPET for HER2+ breast cancer assessment. Long T½ (78h) adapted to antibody pharmacokinetics.
Reference content from the original site. Dates and statuses reflect the sources; no new scientific verification has been performed.
Browse the directory